Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07081841 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

AB-1005 Long-Term Follow-up Study

StatusEnrolling by Invitation
PhaseNot specified
SponsorAskBio Inc
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Enrolling by Invitation Start date changed from estimate of Aug 25, 2025 to Sep 4, 2025 · Site contacts updated at 1 of 2 sitesv2 Show 2 more changesShow less
    • Start date changed from estimate of Aug 25, 2025 to Sep 4, 2025
    • Site contacts updated at 1 of 2 sites
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
AskBio Inc
9 trials monitored
See 3 trials at risk
Parkinson's Disease
1,435 trials monitored
See 62 trials at risk
This is an observational, long term, follow-up study for participants with Parkinson's disease (PD) or Multiple System Atrophy-Parkinsonian subtype (MSA-P) who participated in prior interventional studies with AB-1005. It is intended to better understand the long-term safety of AB-1005, how well tolerated it is and how long lasting the effects are.
Trial Details
NCT Number NCT07081841
Lead Sponsor AskBio Inc
Conditions Parkinson's Disease, Multiple System Atrophy, Parkinson Variant
Enrollment 132 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov